Acute hypopituitarism associated with periorbital swelling and cardiac dysfunction in a patient with pituitary tumor apoplexy: a case report

Table 3 Corticotropin-releasing hormone/growth hormone-releasing factor/luteinizing hormone-releasing hormone stimulation test in July 2016 (day 5 after admission)

	Reference range for basal value	Time (min)
	Reference range for basal value	0 (Basal)	15	30	60	90	120
Serum GH (ng/mL)	0–0.17	0.03	0.41	1.11	1.30	0.92	0.35
Plasma ACTH (pg/mL)	7.2–63.3	15.4	90.1	91.7	75.8	66.5	60.4
Serum cortisol (μg/dL)	4.5–21.1	1.1	2.7	4.5	5.1	5.2	4.9
Serum LH (mIU/mL)	0.8–5.7	0.5	1.0	1.4	1.7	2.0	1.9
Serum FSH (mIU/mL)	2.0–8.3	2.0	2.9	3.1	3.8	3.9	4.0

The following were administered intravenously in the morning (9 AM): 100 μg corticotropin-releasing hormone (CRH), 100 μg growth hormone-releasing factor (GRF), and 100 μg luteinizing hormone-releasing hormone (LHRH)
Our patient had low serum levels of insulin-like growth factor 1 (15 ng/mL; reference range, 48–177) and free testosterone (<0.1 pg/mL; reference range, 4.6–16.9)
ACTH arenocorticotropic hormone, GH growth hormone, FSH follicle-stimulating hormone, LH luteinizing hormone

ISSN: 1752-1947